BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8139849)

  • 1. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should women with familial ovarian cancer undergo prophylactic oophorectomy?
    Kerlikowske K; Brown JS; Grady DG
    Obstet Gynecol; 1992 Oct; 80(4):700-7. PubMed ID: 1407898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial cancer of the ovary. A family with 6 index cases].
    de Meeus JB; Bennouna C; Maréchaud M; Plocoste V; Magnin G
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):749-56. PubMed ID: 8308201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
    Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
    J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial ovarian cancer.
    Elit L
    Can Fam Physician; 2001 Apr; 47():778-84. PubMed ID: 11340759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prophylactic oophorectomy in cancer prevention.
    Averette HE; Nguyen HN
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial ovarian cancer.
    Ngan HY; Shepherd JH
    Br J Hosp Med; 1994 Jul 13-Aug 16; 52(2-3):99-102. PubMed ID: 7952791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
    Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
    J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
    Brain K; Gravell C; France E; Fiander A; Gray J
    Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study.
    Steinberg KK; Pernarelli JM; Marcus M; Khoury MJ; Schildkraut JM; Marchbanks PA
    Genet Epidemiol; 1998; 15(1):51-9. PubMed ID: 9523210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospectively detected cancer in familial breast/ovarian cancer screening.
    Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial neoplastic syndromes of the ovary. A family study].
    Di Vagno G; Nacci G; Cormio G; Loverro G
    Minerva Ginecol; 1994 Oct; 46(10):571-4. PubMed ID: 7838415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.